HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Change in Acquisitions & Divestments (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Change in Acquisitions & Divestments came in at $50.0 million in Q2 2021, down 73.95% year-over-year from $191.8 million in Q2 2020, and down 74.97% quarter-over-quarter from $199.5 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Change in Acquisitions & Divestments (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $50.0 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 73.95% year-over-year to $50.0 million in Q2 2021; TTM through Jun 2021 was $537.3 million, a 8.6% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 20.29% from the prior year.
  • Change in Acquisitions & Divestments was $50.0 million for Q2 2021 at HUTCHMED (China), down from $199.5 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $273.0 million in Q1 2018 and troughed at $50.0 million in Q2 2021.
  • A 4-year average of $174.7 million and a median of $195.7 million in 2020 frame the typical range for Change in Acquisitions & Divestments.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 107.84% in 2021, down 73.95% in 2021.
  • Over 4 years, Change in Acquisitions & Divestments stood at $202.4 million in 2018, then tumbled by 70.4% to $59.9 million in 2019, then jumped by 220.0% to $191.8 million in 2020, then tumbled by 73.95% to $50.0 million in 2021.
  • The last three Change in Acquisitions & Divestments figures came in at $50.0 million (Q2 2021), $199.5 million (Q1 2021), and $191.8 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 49.95 Mn
Mar 31, 2021 199.55 Mn
Jun 30, 2020 191.76 Mn
Mar 31, 2020 96.01 Mn
Dec 31, 2019 59.93 Mn
Sep 30, 2019 147.03 Mn
Jun 30, 2019 180.17 Mn
Mar 31, 2019 209.92 Mn
Dec 31, 2018 202.44 Mn
Sep 30, 2018 242.19 Mn
Jun 30, 2018 244.00 Mn
Mar 31, 2018 273.03 Mn